Emily Byrn

Washington, D.C.

I live with psoriatic arthritis.

Growing up, I always had various injuries and illnesses and tendonitis in nearly every joint. I never had a specific diagnosis to explain all of these symptoms until five years ago. My journey to being diagnosed with psoriatic arthritis was difficult, involving dozens of different medications and doctors trying to figure out a diagnosis.

I eventually was prescribed Humira, which brought relief to my joints with minimal side effects. The only concern was that this prescription carried a list price of over $6,400 per month. And Abbvie, Humira’s manufacturer, has hiked Humira’s price 400% over the past 15 years – I know that price will very likely keep increasing in the future if nothing changes.

I’m lucky that I have insurance that allows me to afford my medication, but I know that could change at any moment. The stress of my drug’s price really weighs on me and affects decisions I make every day and for my future. I think about Humira’s price when I switch jobs — worrying that I might have to pay the list price or a larger portion of the price on different insurance.

Share your story

The prescription drug pricing system in the U.S. is rigged against patients. We are fighting to change that.

Patients For Affordable Drugs will collect patient stories and amplify the voices of patients to make policymakers understand the heavy toll of high priced drugs.

Share your story


Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.